Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDCL3 pseudogene 3 (PDCL3P3) is a pseudogene sequence related to the Phosducin-like 3 gene (PDCL3). Pseudogenes are genomic elements that resemble functional genes but are typically non-coding due to disabling mutations or truncations in their sequences. The PDCL3P3 pseudogene is not documented to produce a functional protein or to be implicated as a therapeutic target, biomarker, or disease gene. Unlike its parent gene (PDCL3), which encodes a chaperone involved in G-protein signaling, apoptosis, and protein folding, PDCL3P3 has no known protein product or biological function because pseudogenes are, by definition, generally nonfunctional remnants of evolutionary gene duplication or retrotransposition[4]. There is no evidence in the literature or biological databases that PDCL3P3 is clinically or therapeutically relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDCL3 pseudogene 3 (PDCL3P3).